RUXOLITINIB
novartis,incyte
['novartis']
please join us today #eha2023 as prof locatelli presents the results of the phase ii reach5 study in pediatric patients with treatment-na ve or steroid-refractory #cgvhd. 
Committed to providing medical & scientific disease education information to healthcare professionals. See our community guidelines: https://t.co/pj8hG1sQAu